Cannell & Spears LLC increased its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 6.4% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 272,505 shares of the conglomerate’s stock after purchasing an additional 16,427 shares during the period. Cannell & Spears LLC’s holdings in Danaher were worth $50,885,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Main Street Group LTD bought a new stake in Danaher in the 1st quarter worth approximately $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the fourth quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.
Key Stories Impacting Danaher
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
- Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
- Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
- Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
- Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Danaher
Danaher Price Performance
Shares of Danaher stock opened at $191.87 on Friday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock’s fifty day moving average is $185.64 and its 200 day moving average is $197.04. The stock has a market cap of $134.88 billion, a P/E ratio of 34.08, a P/E/G ratio of 2.40 and a beta of 0.79. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.65.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the business earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 28.42%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
